Search research articles
Contact Us
Filters
Showing results (21-30 of 115) with videos related to
Page
of 12
Sort By:
Journal of Alzheimer'S Disease : JAD
|
December 20, 2017
Executive and Language Subjective Cognitive Decline Complaints Discriminate Preclinical Alzheimer's Disease from Normal Aging
Natalia Valech, Adrià Tort-Merino, Nina Coll-Padrós, et al.
Revista De Psiquiatria Y Salud Mental
|
October 9, 2012
Somatosensory amplification in schizophrenia is associated with preserved neuropsychological function
Manuel Valdés, Miguel Bernardo, Nuria Segarra, et al.
Dementia and Geriatric Cognitive Disorders
|
October 16, 2007
Longitudinal study of amnesic patients at high risk for Alzheimer's disease: clinical, neuropsychological and magnetic resonance spectroscopy features
Lorena Rami, Beatriz Gómez-Anson, Raquel Sanchez-Valle, et al.
Neuroreport
|
September 18, 2008
Cerebellar deficits in schizophrenia are associated with executive dysfunction
Nuria Segarra, Miguel Bernardo, Manuel Valdes, et al.
Journal of Alzheimer'S Disease : JAD
|
November 25, 2010
Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients
Lorena Rami, Juan Fortea, Beatriz Bosch, et al.
Neuroimage. Clinical
|
March 27, 2019
Mechanisms of functional compensation, delineated by eigenvector centrality mapping, across the pathophysiological continuum of Alzheimer's disease
Stavros Skouras, Carles Falcon, Alan Tucholka, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
December 17, 2010
Different profiles of Alzheimer's disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints
Anna Antonell, Juan Fortea, Lorena Rami, et al.
Journal of Alzheimer'S Disease : JAD
|
July 16, 2014
Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease
Anna Antonell, Alicia Mansilla, Lorena Rami, et al.
Neurobiology of Aging
|
July 9, 2014
White matter changes in preclinical Alzheimer's disease: a magnetic resonance imaging-diffusion tensor imaging study on cognitively normal older people with positive amyloid β protein 42 levels
José Luis Molinuevo, Pablo Ripolles, Marta Simó, et al.
Neuroimage. Clinical
|
July 20, 2018
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets
Carles Falcon, Alan Tucholka, Gemma C Monté-Rubio, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 115) with videos related to
Sort By:
Page
of 12
Journal of Alzheimer'S Disease : JAD
|
December 20, 2017
Executive and Language Subjective Cognitive Decline Complaints Discriminate Preclinical Alzheimer's Disease from Normal Aging
Natalia Valech, Adrià Tort-Merino, Nina Coll-Padrós, et al.
Revista De Psiquiatria Y Salud Mental
|
October 9, 2012
Somatosensory amplification in schizophrenia is associated with preserved neuropsychological function
Manuel Valdés, Miguel Bernardo, Nuria Segarra, et al.
Dementia and Geriatric Cognitive Disorders
|
October 16, 2007
Longitudinal study of amnesic patients at high risk for Alzheimer's disease: clinical, neuropsychological and magnetic resonance spectroscopy features
Lorena Rami, Beatriz Gómez-Anson, Raquel Sanchez-Valle, et al.
Neuroreport
|
September 18, 2008
Cerebellar deficits in schizophrenia are associated with executive dysfunction
Nuria Segarra, Miguel Bernardo, Manuel Valdes, et al.
Journal of Alzheimer'S Disease : JAD
|
November 25, 2010
Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients
Lorena Rami, Juan Fortea, Beatriz Bosch, et al.
Neuroimage. Clinical
|
March 27, 2019
Mechanisms of functional compensation, delineated by eigenvector centrality mapping, across the pathophysiological continuum of Alzheimer's disease
Stavros Skouras, Carles Falcon, Alan Tucholka, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
December 17, 2010
Different profiles of Alzheimer's disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints
Anna Antonell, Juan Fortea, Lorena Rami, et al.
Journal of Alzheimer'S Disease : JAD
|
July 16, 2014
Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease
Anna Antonell, Alicia Mansilla, Lorena Rami, et al.
Neurobiology of Aging
|
July 9, 2014
White matter changes in preclinical Alzheimer's disease: a magnetic resonance imaging-diffusion tensor imaging study on cognitively normal older people with positive amyloid β protein 42 levels
José Luis Molinuevo, Pablo Ripolles, Marta Simó, et al.
Neuroimage. Clinical
|
July 20, 2018
Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets
Carles Falcon, Alan Tucholka, Gemma C Monté-Rubio, et al.
Page
of 12